Heart Test Laboratories Inc.

3.40
0.04 (1.19%)
Jan 23, 2025, 1:54 PM - Market open
1.19%
Bid 3.41
Market Cap 3.33M
Revenue (ttm) 15.71
Net Income (ttm) -8.15K
EPS (ttm) 5.35
PE Ratio (ttm) 0.64
Forward PE -0.46
Analyst Buy
Ask 3.5
Volume 5,501
Avg. Volume (20D) 37,336
Open 3.43
Previous Close 3.36
Day's Range 3.37 - 3.44
52-Week Range 2.36 - 18.50
Beta 3.29

About HSCS

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake...

Sector Healthcare
IPO Date Jun 16, 2022
Employees 15
Stock Exchange NASDAQ
Ticker Symbol HSCS

Analyst Forecast

According to 2 analyst ratings, the average rating for HSCS stock is "Buy." The 12-month stock price forecast is $13.5, which is an increase of 297.06% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts
8 months ago
-38.37%
Heart Test Laboratories shares are trading lower a... Unlock content with Pro Subscription
9 months ago
+9.1%
Heart Test Laboratories shares are trading higher after the company announced its European Patent Office Application EP3834729 has been granted.